Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1632 1635 1699
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18026474 | CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE | Final Rejection | Konica Minolta, Inc. |
| 18416749 | METHODS FOR SCREENING GENETIC PERTURBATIONS | Final Rejection | The Regents of the University of California |
| 17549028 | PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE | Final Rejection | The Regents of the University of Michigan |
| 18696014 | TREATMENT OF POLYCYTHEMIA VERA VIA CRISPR/AAV6 GENOME EDITING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17168988 | ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 16968941 | DECELLULARIZED TISSUES, HYDROGELS THEREOF, AND USES THEREOF | Final Rejection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION |
| 17757503 | T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 16960445 | 3D in vitro Models of Lung Tissue | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 17669904 | DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY | Non-Final OA | The General Hospital Corporation |
| 17495597 | MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES | Final Rejection | Wisconsin Alumni Research Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy